Cefscot-TZ 1.125gm Injection
Marketer
Scotwin Healthcare
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefscot-TZ 1.125gm Injection
Ceftriaxone and Sulbactam 1.125g injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and preventing infection spread. Administration must be solely under a doctor's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is essential, even with symptom improvement. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and upset stomach. Severe or worsening side effects require immediate medical attention. Seek immediate medical help for allergic reactions (skin rash, itching, swelling, breathing difficulties). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or nursing individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order blood tests and other evaluations to monitor your response to the medication.
Primary Ingredients of Cefscot-TZ 1.125gm Injection
No text provided to rephrase.
Uses of Cefscot-TZ 1.125gm Injection
Infections caused by bacteria
Major Benefits of Cefscot-TZ 1.125gm Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Cefscot-TZ 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefscot-TZ 1.125gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefscot-TZ 1.125gm Injection works:
Ceftriaxone and Tazobactum, combined as Cefscot-TZ 1.125gm Injection, offer a dual-action antibiotic approach. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefscot-TZ 1.125gm Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefscot-TZ 1.125gm is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
The antibiotic Cefscot-TZ 1.125gm Injection requires careful consideration when administered to breastfeeding mothers. Lactation should be temporarily suspended throughout the course of treatment and until the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Cefscot-TZ 1.125gm Injection may induce drowsiness, visual disturbances, or dizziness. Driving is discouraged if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefscot-TZ 1.125gm Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The use of Cefscot-TZ 1.125gm Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Cefscot-TZ 1.125gm Injection dosage is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefscot-TZ 1.125gm Injection :
Omitting a scheduled dose of Cefscot-TZ 1.125gm Injection necessitates contacting your physician.
Facts to Know About Cefscot-TZ 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently